These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35709440)

  • 1. Protecting Against Opioid Overdose: Naloxone Co-Prescribing.
    Nathan N
    Anesth Analg; 2022 Jul; 135(1):20. PubMed ID: 35709440
    [No Abstract]   [Full Text] [Related]  

  • 2. Naloxone for Opioid Overdose: Comment.
    Milas BL; Varon AJ
    Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone for Opioid Overdose: Comment.
    Pattullo GG
    Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose.
    Kispert D; Carwile JL; Silvia KB; Eisenhardt EB; Thakarar K
    J Gen Intern Med; 2020 May; 35(5):1603-1605. PubMed ID: 31625039
    [No Abstract]   [Full Text] [Related]  

  • 5. The innovative role of an "opioid overdose prevention pharmacist" at a mental health teaching hospital.
    Costa T; Zhang M
    Am J Health Syst Pharm; 2021 Feb; 78(4):292-296. PubMed ID: 33471052
    [No Abstract]   [Full Text] [Related]  

  • 6. Opioid overdose knowledge among college students compared to experienced opioid users.
    Jones JD; Avila JR; Smith MK; Martinez S
    Drug Alcohol Rev; 2024 Jan; 43(1):343-346. PubMed ID: 37920901
    [No Abstract]   [Full Text] [Related]  

  • 7. The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for Patients at Risk for Opioid Overdose.
    Benzon HT; Sun EC; Chou R
    Anesth Analg; 2022 Jul; 135(1):21-25. PubMed ID: 35709441
    [No Abstract]   [Full Text] [Related]  

  • 8. Opioid Overdose Harm Prevention: The Role of the Nurse in Patient Education.
    Gilles S
    Nurs Clin North Am; 2022 Sep; 57(3):477-488. PubMed ID: 35985734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone Over the Counter: Increasing Opportunities and Challenges for Health Providers.
    Ardeljan AD; Fiedler B; Fiedler L; Luck GR; Maki DG; Clayton L; Hennekens CH; Ferris A
    Am J Med; 2023 Jun; 136(6):504-506. PubMed ID: 36750143
    [No Abstract]   [Full Text] [Related]  

  • 10. Intranasal Naloxone for Opioid Overdose.
    Taylor JL; Lasser KE
    JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying and Evaluating the Opioid Overdose Knowledge Scale for Prescription Opioids: A Pilot Study of the Rx-OOKS.
    Shoup JA; Mueller SR; Binswanger IA; Williams AV; Strang J; Glanz JM
    Pain Med; 2020 Oct; 21(10):2244-2252. PubMed ID: 32827044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Take-home Naloxone at Opioid Treatment Programs: A Lifesaver.
    Katzman JG; Bhatt S; Comerci GD
    J Addict Med; 2022 Nov-Dec 01; 16(6):619-621. PubMed ID: 35220332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone receipt and overdose prevention care among people with HIV on chronic opioid therapy.
    Kimmel SD; Walley AY; Lodi S; Forman LS; Liebschutz JM; Lira MC; Kim TW; Del Rio C; Samet JH; Tsui JI
    AIDS; 2021 Mar; 35(4):697-700. PubMed ID: 33587441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zimhi - a higher-dose injectable naloxone for opioid overdose.
    Med Lett Drugs Ther; 2022 Apr; 64(1648):61-62. PubMed ID: 35436775
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs.
    Patel SV; Wenger LD; Kral AH; Sherr K; Wagner AD; Davidson PJ; Lambdin BH
    BMC Health Serv Res; 2023 Mar; 23(1):278. PubMed ID: 36949494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piloting a statewide emergency department take-home naloxone program: Improving the quality of care for patients at risk of opioid overdose.
    Dora-Laskey A; Kellenberg J; Dahlem CH; English E; Gonzalez Walker M; Brummett CM; Kocher KE
    Acad Emerg Med; 2022 Apr; 29(4):442-455. PubMed ID: 34962682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of opioid overdose education and naloxone distribution in New York City.
    Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
    Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.